# EML4

Source: https://onco.cc/targets/eml4/  
OnCo record `eml4` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

EML4 (Echinoderm microtubule-associated protein-like 4) is a gene. The public catalogues list it as a drug target and a fusion partner, and an approved or late-stage drug is recorded against it. Tied to Lung cancer, Thyroid cancer and Non-small-cell lung cancer.

## Summary

Essential for the formation and stability of microtubules (MTs). Required for the organisation of the mitotic spindle and for the proper attachment of kinetochores to MTs. Promotes the recruitment of NUDC to the mitotic spindle for mitotic progression.

Open Targets scores its association with cancer at 0.84 (direct and indirect evidence; datatypes clinical 0.99, affected pathway 0.94, literature 0.98, genetic association 0.41, somatic mutation 0.98).

## Fields

- Kind: Target
- Last checked: 2026-09-23
- Also known as: EMAP like 4; Echinoderm microtubule-associated protein-like 4; ROPP120; ELP120; C2orf2
- Tags: cancer-genes-wave
- Symbol: EML4
- Class: other
- Biology: Essential for the formation and stability of microtubules (MTs). Required for the organisation of the mitotic spindle and for the proper attachment of kinetochores to MTs. Promotes the recruitment of NUDC to the mitotic spindle for mitotic progression. Location: Cytoplasm, cytoskeleton; Cytoplasm; Cytoplasm, cytoskeleton, spindle; Cytoplasm, cytoskeleton, microtubule organizing center (UniProt). Locus 2p21 (HGNC).
- Where found: Lung cancer: Open Targets association 0.76 with lung cancer (MONDO_0008903); Thyroid cancer: Open Targets association 0.55 with thyroid cancer (MONDO_0002108); Non-small-cell lung cancer: Open Targets association 0.75 with non-small cell lung carcinoma (MONDO_0005233)

## Notes

- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: Open Targets known-drug datatype score 0.99; UniProt disease notes describe a translocation or gene fusion involving the gene. Evidence tier "approved-drug" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.

## Sources

- HGNC HGNC:1316: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1316
- UniProt Q9HC35: https://www.uniprot.org/uniprotkb/Q9HC35/entry
- NCBI Gene 27436: https://www.ncbi.nlm.nih.gov/gene/27436
- Ensembl ENSG00000143924: https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143924

## Connected records

- collections: [Open Targets Platform](https://onco.cc/collections/open-targets/)
- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Thyroid cancer](https://onco.cc/cancers/thyroid/)

---
JSON: https://onco.cc/api/v1/entities/eml4.json